Recombinant multi-species ATF4/ATF-4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATF4/ATF-4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a transcription factor that was originally identified as a widely expressed mammalian DNA binding protein that could bind a tax-responsive enhancer element in the LTR of HTLV-1. The encoded protein was also isolated and characterized as the cAMP-response element binding protein 2 (CREB-2). The protein encoded by this gene belongs to a family of DNA-binding proteins that includes the AP-1 family of transcription factors, cAMP-response element binding proteins (CREBs) and CREB-like proteins. These transcription factors share a leucine zipper region that is involved in protein-protein interactions, located C-terminal to a stretch of basic amino acids that functions as a DNA binding domain. Two alternative transcripts encoding the same protein have been described. Two pseudogenes are located on the X chromosome at q28 in a region containing a large inverted duplication. [provided by RefSeq, Sep 2011]
The Alternative Names of target: ATF4, ATF-4,Cyclic AMP-dependent transcription factor ATF-4,cAMP-dependent transcription factor ATF-4,Activating transcription factor 4, Cyclic AMP-responsive element-binding protein 2 (CREB-2, cAMP-responsive element-binding protein 2), Tax-responsive enhancer element-binding protein 67 (TaxREB67),CREB2,TXREB,CREB-2,TAXREB67
Go
to ATF4/ATF-4 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T53270-Ab-1/ GM-Tg-hg-T53270-Ab-2 | Human ATF4/ATF-4 protein | Human |
GM-Tg-rg-T53270-Ab-1/ GM-Tg-rg-T53270-Ab-2 | Rat ATF4/ATF-4 protein | Rat |
GM-Tg-mg-T53270-Ab-1/ GM-Tg-mg-T53270-Ab-2 | Mouse ATF4/ATF-4 protein | Mouse |
GM-Tg-cynog-T53270-Ab-1/ GM-Tg-cynog-T53270-Ab-2 | Cynomolgus/Rhesus macaque ATF4/ATF-4 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T53270-Ab-1/ GM-Tg-felg-T53270-Ab-2 | Feline ATF4/ATF-4 protein | Feline |
GM-Tg-cang-T53270-Ab-1/ GM-Tg-cang-T53270-Ab-2 | Canine ATF4/ATF-4 protein | Canine |
GM-Tg-bovg-T53270-Ab-1/ GM-Tg-bovg-T53270-Ab-2 | Bovine ATF4/ATF-4 protein | Bovine |
GM-Tg-equg-T53270-Ab-1/ GM-Tg-equg-T53270-Ab-2 | Equine ATF4/ATF-4 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T53270-Ab-1/ GM-Tg-hg-T53270-Ab-2;
GM-Tg-rg-T53270-Ab-1/ GM-Tg-rg-T53270-Ab-2;
GM-Tg-mg-T53270-Ab-1/ GM-Tg-mg-T53270-Ab-2; GM-Tg-cynog-T53270-Ab-1/ GM-Tg-cynog-T53270-Ab-2; GM-Tg-felg-T53270-Ab-1/ GM-Tg-felg-T53270-Ab-2; GM-Tg-cang-T53270-Ab-1/ GM-Tg-cang-T53270-Ab-2; GM-Tg-bovg-T53270-Ab-1/ GM-Tg-bovg-T53270-Ab-2; GM-Tg-equg-T53270-Ab-1/ GM-Tg-equg-T53270-Ab-2 |
Products Name | ATF4/ATF-4 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | ATF4/ATF-4 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATF4/ATF-4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.